Study of COVID-19 Pandemic in Representative Dialysis Population Across Mumbai, India: An Observational Multicentric

Rushi Deshpande1, Sudhiranjan Dash2, M M Bahadur3

  • 1Department of Nephrology at Jaslok Hospital and Research Center, Mumbai, Maharashtra; Reliance HN Hospital, Mumbai, Maharastra.

Insights

The COVID-19 pandemic significantly impacted hemodialysis patients, with a 6.4% prevalence and 12% mortality. Elderly patients with comorbidities faced poorer prognoses, highlighting the need for enhanced safety measures in dialysis units.

Area of Science:

  • Infectious Diseases
  • Nephrology
  • Public Health

Background:

  • The COVID-19 pandemic poses significant risks, particularly to vulnerable populations like the elderly and those with comorbidities.
  • Hemodialysis patients are at increased risk of COVID-19 infection due to patient, environmental, and procedural factors.
  • Limited data exists on COVID-19 prevalence and outcomes specifically within the hemodialysis population.

Purpose of the Study:

  • To determine the prevalence and characteristics of COVID-19 infection in hemodialysis patients in Mumbai.
  • To identify risk factors associated with poor outcomes in this population.
  • To assess the impact of COVID-19 on healthcare workers in dialysis units.

Main Methods:

  • A cross-sectional study was conducted across multiple hemodialysis centers in Mumbai.
  • Data collected included patient demographics, comorbidities, COVID-19 status, and outcomes.
  • Healthcare worker infections and the efficacy of hydroxychloroquine chemoprophylaxis were also evaluated.

Main Results:

  • COVID-19 prevalence was 6.4% among hemodialysis patients, with a 12% mortality rate.
  • Elderly patients and those with comorbidities had a poorer prognosis.
  • Patients with COPD, requiring ICU care, or ventilation had worse outcomes, while cardiovascular disease did not predict poor outcomes.
  • 1.5% of non-COVID hemodialysis patients died due to lack of dialysis access.
  • 4.1% of healthcare workers contracted COVID-19, with all recovering; hydroxychloroquine chemoprophylaxis showed no statistically significant benefit.

Conclusions:

  • Hemodialysis patients, especially the elderly with comorbidities, are at high risk for severe COVID-19 outcomes.
  • Lack of dialysis access is a critical issue contributing to mortality.
  • Enhanced infection control measures, treating all patients as potential COVID-19 suspects, are crucial in resource-limited dialysis settings.
  • Further research is needed to optimize care for this vulnerable group.

Related Concept Videos

Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.3K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
953
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
824
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
377
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
273
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
509